CV Sciences, Inc. Share Price Other OTC
Equities
CVSI
US1266541028
Pharmaceuticals
Sales 2022 | 16.2M 1.35B | Sales 2023 | 16M 1.33B | Capitalization | 5.47M 455M |
---|---|---|---|---|---|
Net income 2022 | -9M -749M | Net income 2023 | 3M 250M | EV / Sales 2022 | 0.36 x |
Net Debt 2022 | 917K 76.35M | Net cash position 2023 | 875K 72.85M | EV / Sales 2023 | 0.29 x |
P/E ratio 2022 |
-0.44
x | P/E ratio 2023 |
1.77
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.98% |
Latest transcript on CV Sciences, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 16/14/16 |
Joerg Grasser
DFI | Director of Finance/CFO | 49 | 26/18/26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 16/14/16 |
Jamie Corroon
BRD | Director/Board Member | 54 | 21/22/21 |
William McCorkle
BRD | Director/Board Member | 56 | 21/22/21 |
1st Jan change | Capi. | |
---|---|---|
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |